15 Amendments of Theodoros SKYLAKAKIS related to 2012/0366(COD)
Amendment 62 #
Proposal for a directive
Recital 3 a (new)
Recital 3 a (new)
(3a) Health warning serves as a part of an organised, effective and long term anti- smoking strategy, with well defined scope and objectives.
Amendment 78 #
Proposal for a directive
Recital 9 a (new)
Recital 9 a (new)
(9 a) Given that in many Member States large percentages of smokers are unlikely to stop smoking entirely, legislation should take into account their right to know objectively the impact the possible use of tobacco has on their health - information which they also receive through the packaging of the product they are likely to use.
Amendment 89 #
Proposal for a directive
Recital 13
Recital 13
(13) The current use of different reporting formats makes it difficult for manufacturers and importers to fulfil their reporting obligations and burdensome for the Member States and the Commission to compare, analyse and draw conclusions from the information received. In this light there should be a common mandatory format for the reporting of ingredients and emissions. The greatest possible transparency of product information, allowing enough space for this information on the unit packets, should be ensured for the general public, while ensuring that appropriate account is taken of the commercial and intellectual property rights of the manufacturers of tobacco products.
Amendment 190 #
Proposal for a directive
Recital 31
Recital 31
(31) All tobacco products have the potential to cause mortality, morbidity and disability and their consumption should be contained. It is therefore important to monitor developments as regards novel tobacco products. A notification obligation for novel tobacco products should be put on manufacturers and importers, without prejudice to the power of the Member States to ban or to authorise them. In so doing, Member States should take into account the possibility that new tobacco products may have a negative impact on the overall health of the population or the possibility that new tobacco products may limit the damage to the overall health of the population through the mass substitution of products used by smokers and the insignificant use of these products by non-smokers. The Commission should monitor the development, bearing in mind both possibilities, and submit a report 53 years after the transposition deadline of this Directive, in order to assess whether amendments to this Directive are necessary.
Amendment 203 #
Proposal for a directive
Recital 34
Recital 34
(34) Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use provides a legal framework to assess the quality, safety and efficacy of medicinal products including nicotine containing products. A significant number of nicotine-containing products were already authorised under this regulatory regime. However, it is necessary to differentiate them from non- pharmaceutical nicotine-containing products aimed at smokers whose use is aimed primarily not at stopping tobacco use but at replacing existing tobacco products and whose impact on the overall health of the population is drastically different from that of existing tobacco products. The authorisation takes into account the nicotine content of the product in question. Subjecting all nicotine- containing products, whose nicotine content equals or exceeds the content of a nicotine containing product previously authorised under Directive 2001/83/EC, to the same legal framework clarifies the legal situation, levels out differences between national legislations, ensures equal treatment of all nicotine containing products usable for smoking cessation purposes and creates incentives for research and innovation in smoking cessation. This should be without prejudice to the application of Directive 2001/83/EC to other products covered by this Directive if the conditions set by Directive 2001/83/EC are fulfilled.
Amendment 339 #
Proposal for a directive
Article 2 – paragraph 1 – point 30
Article 2 – paragraph 1 – point 30
(30) 'substantial change of circumstances' means an increase of the sales volumes by product category, such as pipe tobacco, cigar, cigarillo, by at least 10% in at least 10 Member States based on sales data transmitted in accordance with Article 5(4); or an increase of the prevalence level in the consumer group under 25 years of age by at least 5 percentage points in at least 10 Member States for the respective product category based on ____ [this date will be set at the moment of adoption of the Directive] Eurobarometer report or equivalent prevalence studies, provided, however, that the increases in both these cases are higher than 0.1% in the total market in tobacco products;
Amendment 349 #
Proposal for a directive
Article 2 – paragraph 1 – point 36
Article 2 – paragraph 1 – point 36
(36) ‘unit packet’ means the smallest individual packaging of a product that is placed on the market and is available to the final consumer.
Amendment 434 #
Proposal for a directive
Article 5 – paragraph 4
Article 5 – paragraph 4
4. Member States shall require manufacturers and importers to submit internal and external studies available to them on market research and preferences of various consumer groups, including young people and chronic heavy smokers, relating to ingredients and emissions. Member States shall also require manufacturers and importers to report the sales volume data per product, reported in sticks or kilograms, and per Member State on a yearly basis starting from the full calendar year following that of the entry into force of this Directive. Member States shall provide alternative or additional sales data, as appropriate, to ensure that information on sales volume requested under this paragraph is reliable and complete.
Amendment 544 #
Proposal for a directive
Article 6 – paragraph 7 – subparagraph 1
Article 6 – paragraph 7 – subparagraph 1
Member States shall, based on scientific evidence, prohibit the placing on the market of tobacco products with additives in quantities that increase in an appreciable manner at the stage of consumption the toxic or addictive effetal health impact of a tobacco product.
Amendment 622 #
Proposal for a directive
Article 8 – paragraph 3
Article 8 – paragraph 3
3. For cigarette packets the general warning and the information message shall be printed on the lateral sides of the unit packets. These warnings shall have a width of not less than 20 mm and a height of not less than 43 mm for cuboids and for shoulder packets. For roll-your-own tobacco the information message shall be printed on the surface that becomes visible when opening the unit packet. Both the general warning and the information message shall cover 50% of the surface on which they are printed.
Amendment 731 #
Proposal for a directive
Article 9 – paragraph 2
Article 9 – paragraph 2
2. The combined health warnings shall be divided into three sets rotating on an annual basis. Member States shall ensure that each combined health warning is displayed as nearly as possible on equal numbers of each brand. As part of a specific anti-smoking campaign, Member States may, for domestically produced tobacco products intended for domestic consumption, adapt the use of the verbal warnings listed in Annex 1, as well as the use of images and photographs, to the purposes of the campaign in question.
Amendment 886 #
Proposal for a directive
Article 13 – paragraph 1
Article 13 – paragraph 1
1. A unit packet of cigarettes shall have a cuboid or a shoulder shape. A unit packet of roll-your- own tobacco shall have the form of a pouch, i.e. a rectangular pocket with a flap that covers the opening. The flap of the pouch shall cover at least 70% of the front of the packet. A unit packet of cigarettes shall include at least 20 cigarettes. A unit packet of roll-your-own tobacco shall contain tobacco weighing at least 40 g.
Amendment 896 #
Proposal for a directive
Article 13 – paragraph 2
Article 13 – paragraph 2
2. A cigarette packet can be of carton or soft material and shall not contain an opening that can be re-closed or re-sealed after the opening is first opened, other than the flip-top lid. The flip-top lid of a cuboid cigarette packet shall be hinged only at the back of the packet.
Amendment 1130 #
Proposal for a directive
Article 17 – paragraph 1 – point b
Article 17 – paragraph 1 – point b
b) available studies and market research on preferences of various consumer groups, including young people and chronic heavy smokers and
Amendment 1220 #
Proposal for a directive
Article 18 – paragraph 2 a (new)
Article 18 – paragraph 2 a (new)
2a. Paragraphs 1 and 2 shall not apply to products whose entry onto the market is likely to lead to a significant improvement in the overall health of the population, taking into account both the degree to which they replace more harmful tobacco products, and the extent to which they are adopted by non-users of tobacco products. The decision shall be taken by Member States.